North American Molecular Diagnostics Market Size, Share & Trends Analysis Report By Technology, By Application (Oncology, CVD), By Test Location (PoC, OTC), By Product (Instruments, Reagents), And Segment Forecasts, 2018 - 2025

马克t Segmentation

• North America MDx Product Outlook (Revenue, USD Million, 2014 - 2025)
  • Instruments
  • Reagents
• North America MDx Test Location Outlook (Revenue, USD Million, 2014 - 2025)
  • Point-of-Care (PoC)
  • Self-test or Over the Counter (OTC)
  • Central Laboratories
• North America MDx Technology Outlook (Revenue, USD Million, 2014 - 2025)
  • Polymerase chain reaction (PCR)
    • Multiplex PCR
    • Other PCR
  • In Situ Hybridization
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Chips and Microarrays
  • Mass Spectrometry
  • Sequencing
  • Transcription Mediated Amplification
  • Others
• North America MDx ApplicationOutlook (Revenue, USD Million, 2014 - 2025)
  • Oncology
    • Breast Cancer
    • Prostate Cancer
    • Colorectal Cancer
    • Cervical Cancer
    • Kidney Cancer
    • Liver Cancer
    • Blood Cancer
    • Lung Cancer
    • Other Cancer
  • Pharmacogenomics
  • Infectious Diseases
    • Methicillin-resistant Staphylococcus Aureus (MRSA)
    • Clostridium Difficile
    • Vancomycin-resistant Enterococci (VRE)
    • 特拉细菌
    • Flu
    • Respiratory Syncytial Virus (RSV)
    • Candida
    • Tuberculosis and drug-resistant TBA
    • Meningitis
    • Gastrointestinal Panel Testing
    • Chlamydia
    • Gonorrhea
    • HIV
    • Hepatitis C
    • Hepatitis B
    • Other Infectious Disease
  • Genetic Testing
    • Newborn Screening
    • Predictive and Presymptomatic Testing
    • Other Genetic Testing
  • Neurological Disease
  • Cardiovascular Disease
  • Microbiology
  • Others
• North America MDx Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • The U.S.
    • U.S Molecular Diagnostics Market, by Product
      • Instruments
      • Reagents
    • U.S. Molecular Diagnostics Market, by Test Location
      • Point-of-Care
      • Self-test or Over the Counter
      • Central Laboratories
    • U.S. Molecular Diagnostics Market, by Technology
      • Polymerase chain reaction (PCR)
        • Multiplex PCR
        • Other PCR
      • In Situ Hybridization
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • Chips and Microarrays
      • Mass Spectrometry
      • Sequencing
      • Transcription Mediated Amplification
      • Others
    • U.S. Molecular Diagnostics Market, by Application
      • Oncology
        • Breast Cancer
        • Prostate Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Kidney Cancer
        • Liver Cancer
        • Blood Cancer
        • Lung Cancer
        • Other Cancer
      • Pharmacogenomics
      • Infectious Diseases
        • Methicillin-resistant Staphylococcus Aureus (MRSA)
        • Clostridium Difficile
        • Vancomycin-resistant Enterococci (VRE)
        • 特拉细菌
        • Flu
        • Respiratory Syncytial Virus (RSV)
        • Candida
        • Tuberculosis and drug-resistant TBA
        • Meningitis
        • Gastrointestinal Panel Testing
        • Chlamydia
        • Gonorrhea
        • HIV
        • Hepatitis C
        • Hepatitis B
        • Other Infectious Disease
      • Genetic Testing
        • Newborn Screening
        • Predictive and Presymptomatic Testing
        • Other Genetic Testing
      • Neurological Disease
      • Cardiovascular Disease
      • Microbiology
      • Others
  • Canada
    • Canada Molecular Diagnostics Market, by Product
      • Instruments
      • Reagents
    • Canada Molecular Diagnostics Market, by Test Location
      • Point-of-Care
      • Self-test or Over the Counter
      • Central Laboratories
    • Canada Molecular Diagnostics Market, by Technology
      • Polymerase chain reaction (PCR)
        • Multiplex PCR
        • Other PCR
      • In Situ Hybridization
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
      • Chips and Microarrays
      • Mass Spectrometry
      • Sequencing
      • Transcription Mediated Amplification
      • Others
    • Canada Molecular Diagnostics Market, by Application
      • Oncology
        • Breast Cancer
        • Prostate Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Kidney Cancer
        • Liver Cancer
        • Blood Cancer
        • Lung Cancer
        • Other Cancer
      • Pharmacogenomics
      • Infectious Diseases
        • Methicillin-resistant Staphylococcus Aureus (MRSA)
        • Clostridium Difficile
        • Vancomycin-resistant Enterococci (VRE)
        • 特拉细菌
        • Flu
        • Respiratory Syncytial Virus (RSV)
        • Candida
        • Tuberculosis and drug-resistant TBA
        • Meningitis
        • Gastrointestinal Panel Testing
        • Chlamydia
        • Gonorrhea
        • HIV
        • Hepatitis C
        • Hepatitis B
        • Other Infectious Disease
      • Genetic Testing
        • Newborn Screening
        • Predictive and Presymptomatic Testing
        • Other Genetic Testing
      • Neurological Disease
      • Cardiovascular Disease
      • Microbiology
      • Others

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• 马克t drivers and restraints
• 乐鱼体育手机网站入口
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• 马克t size, estimates, and forecast from 2014 to 2025
• 马克t estimates and forecast for product segments up to 2025
• Regional market size and forecast for product segments up to 2025
• 马克t estimates and forecast for application segments up to 2025
• Regional market size and forecast for application segments up to 2025
• 公司金融性能rmance